Nabil Adra

Join our expert panel to explore evolving treatment sequencing in Advanced RCC. Discover insights on frontline decisions, adjuvant strategies & toxicity management to support long-term patient care. Watch the series today: hubs.li/Q047N0_F0 @montypal @cityofhope @DrVaishampayan @UMichMedSchool @alantanmd @VUMCDiscoveries

Honored to share insights on surveillance after complete response to 1L chemotherapy in NSGCT (presented at ASCO GU 2026) @nabiladra. Thank you @VuMedi for the opportunity! Watch here: vumedi.com/video/ascor-gu… #Oncology #TesticularCancer #ASCOGU

@DrKarineTawagi @PGrivasMDPhD @IntegrityCE @tompowles1 @shilpaonc @montypal @cvulsteke @y_loriot @DrYukselUrun @MaxKates @Uromigos @drenriquegrande @AmandaNizamMD @koshkin85 @apolo_andrea @MikeSerzanMD @MattGalsky @ALLIANCE_org @bergsa83 @DrRosenbergMSK @ChadTangMD @DrSpratticus #TumorBoardTuesday 🙏Thank you @PGrivasMDPhD and @DrKarineTawagi for taking us through these cases ➡️It is amazing how quickly treatment paradigms are changing in this disease space, leading to better and better patient outcomes 😀We look forward to further updates next year

@CParkMD and @PGrivasMDPhD starting 2026 MATOS GU meeting with more than 40 KOLs! @EddieSantosMD @edgardo_ny @mecmededucation

Congrats to Umang Swami @umangtalking on being recognized as one of the Top Reviewers of @JCO_ASCO for 2025👉Peer review is the backbone of scientific progress, and this honor reflects his intelligence, rigor, and commitment to advancing cancer research. @huntsmancancer @ASCO

Congratulations to my colleague @rohitjainMD on this important IIT of FGFR3i + EV in metastatic urothelial cancer #BladderCancer #GU26 @WCMGUcancer

💡 18 years ago, I met Dr. Lawrence Einhorn. My 1st mentor. He is an elite clinician. Trial pioneer. Exceptional human. At @ASCO #GU26 we had our annual @OncLive Fellows Forum. ⭐️Loved hearing the trainees present their cancer research and the impact their mentors had on their careers. Mentorship doesn’t just build careers. It builds the future of cancer care. 🔬✨ Grateful to see you at #GU26 Dr. Einhorn. @NazliDizman @MarcMachaalani @JeffreyYZhong @AksheeBatra @KalantriShreyas @PGrivasMDPhD @montypal @DrChoueiri @neerajaiims @DrRanaMcKay @CaPsurvivorship @TDorffOnc @DrYukselUrun @yekeduz_emre @oncodaily

Congratulations to the Indiana team with @JenniferKingMD and @nabiladra presenting cabozantinib in refractory GCT, CBR 43%, very tough area to make progress, glad to see multiple MOAs advancing to try and bring better options for this patient population